(Q36820133)

16 August 2017

1 reference

title

Controversial issues in the management of pancreatic cancer: Part Two. A debate held at St Mary's Hospital, London on 18 November 1993. (English)

1 reference

16 August 2017

1 reference

Glazer G

1

1 reference

16 August 2017

Coulter C

2

1 reference

16 August 2017

Crofton ME

3

1 reference

16 August 2017

Gedroyc WM

4

1 reference

16 August 2017

Johnson CD

5

1 reference

16 August 2017

Mallinson CN

6

1 reference

16 August 2017

Russell RC

7

1 reference

16 August 2017

Steer ML

8

1 reference

16 August 2017

Summerfield JA

9

1 reference

16 August 2017

Williamson RC

10

1 reference

16 August 2017

1 May 1995

1 reference

Annals of the Royal College of Surgeons of England

16 August 2017

1 reference

16 August 2017

77

1 reference

16 August 2017

3

1 reference

16 August 2017

174-180

1 reference

Pancreas cancer resection outcome in American University centers in 1989-1990.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Prognostic factors for survival after pancreaticoduodenectomy for malignant disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Chemotherapy for pancreatic cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Radiotherapy in the treatment of pancreatic cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Carcinoma of the pancreas and papilla of Vater--assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Treatment of pancreatic carcinoma: the surgeon's dilemma.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2502082

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

5 September 2018

1 reference

12 December 2020

Should further studies of chemotherapy be carried out in pancreatic cancer?

1 reference

12 December 2020

Resection for adenocarcinoma of the body and tail of the pancreas

1 reference

12 December 2020

Carcinoma of the pancreas and periampullary region: palliation versus cure

1 reference

12 December 2020

Cancer of the pancreas

1 reference

12 December 2020

Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.

1 reference

12 December 2020

Surgical treatment for carcinoma of the pancreas. Experience in 272 patients

1 reference

12 December 2020

Improved hospital morbidity, mortality, and survival after the Whipple procedure

1 reference

12 December 2020

Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer

1 reference

12 December 2020

Surgical treatment of ductal pancreatic carcinoma

1 reference

12 December 2020

The pattern of lymph node involvement in carcinoma of the head of the pancreas. A histologic study of the surgical findings in patients undergoing extensive nodal dissections

1 reference

12 December 2020

Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study

1 reference

12 December 2020

Identifiers

1 reference

16 August 2017

PubMed publication ID

7598413

1 reference